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Abstract
Multipotent human bone marrow- derived mesenchymal stem cells (hMSCs) are prom-
ising candidates for bone and cartilage regeneration. Toll- like receptor 4 (TLR4) is 
expressed by hMSCs and is a receptor for both exogenous and endogenous danger 
signals. TLRs have been shown to possess functional differences based on the spe-
cies (human or mouse) they are isolated from therefore, the effects of knockdown of 
TLR4 were evaluated in humans during the differentiation of MSCs into bone, fat and 
chondrocyte cells in vitro. We investigated the expression profile of TLR4 during the 
differentiation of hMSCs into three different lineages on days 7, 14 and 21 and as-
sessed the differentiation potential of the cells in the presence of lipopolysaccharide 
(LPS, as an exogenous agonist) and fibronectin fragment III- 1c (FnIII- 1c, as an endog-
enous agonist). TLR4 expression increased following the induction of hMSC differ-
entiation into all three lineages. Alkaline phosphatase activity revealed that FnIII- 1c 
accelerated calcium deposition on day 7, whereas LPS increased calcium deposition 
on day 14. Chondrogenesis increased in the presence of LPS; however, FnIII- 1c acted 
as a reducer in the late stage. TLR4 silencing led to decreased osteogenesis and in-
creased adipogenesis. Furthermore, Wnt5a expression was inversely related to chon-
drogenesis during the late stage of differentiation. We suggest that understanding 
the functionality of TLR4 (in the presence of pathogen or stress signal) during the dif-
ferentiation of hMSCs into three lineages would be useful for MSC- based treatments.
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1  | INTRODUC TION
Multipotent adult mesenchymal stem cells (MSCs) are adherent, 
fibroblast- like and non- hematopoietic cells, that have the capa-
bility to self- renew and differentiate into three lineages including 
osteoblasts, chondrocytes and adipocytes.1,2 It is well known that 
MSCs have a role in the regulation of proliferation, migration, dif-
ferentiation and immunomodulation of cells.3,4 It is necessary to 
understand how these functions are regulated by MSCs. The ex-
pression of TLRs was observed on different types of cells.5,6 TLRs 
are also expressed on stem/progenitor cells and have been shown 
to control the survival, proliferation, differentiation and migration 
of these cells.7 Therefore, it is possible that MSCs perform many 
of their functions through TLRs.8- 11 TLRs are type- I transmem-
brane glycoproteins comprising two domains, the leucine- rich 
repeat (LRP) domain that can identify pathogen- associated mo-
lecular patterns (PAMPs) and the Toll/IL- 1 receptor (TIR) domain 
that activates adaptor molecules including myeloid differentiation 
primary response 88 (MYD88), TIR domain receptor- associated 
protein (TIRAP), TRIF- related adaptor molecule (TRAM) and TIR 
domain- containing adaptor protein inducing INF- β (TRIF).12 Finally, 
nuclear factor kappa B (NF- kB) and mitogen- activated protein ki-
nase (MAPK) are activated that enhance the production of proin-
flammatory cytokines.13
In addition to PAMPs (such as lipopolysaccharides),13 TLRs are 
also activated in the presence of heat- shock proteins (HSPs), S100 
proteins and extracellular matrix fragments that named damage- 
associated molecular patterns (DAMPs) (such as fibronectin). 
DAMPs are released upon alteration in the structures of tissues, cel-
lular stress or tissue damage.14- 16 The FnIII- 1c is a Type III domain of 
fibronectin that, as a component of extracellular matrix molecules 
(ECM) can activate TLR4 signalling. Mechanical injury and tissue 
damage could drive the fate of hMSCs via TLRs.17 TLRs when trig-
gered have a regulatory role in immune regulation, migration and 
the recruitment of MSCs in damaged tissues.10 We investigated how 
the presence of pathogens and stress/danger signals affects the sig-
nalling pathway of TLR4 during the differentiation of hMSCs into 
three different lineages. The role of Wnt5a in response to inflam-
mation18 and differentiation19 in MSCs has been shown previously. 
The Wnt5a acts via the non- canonical pathway and is involved in 
osteogenesis.20 The WNT5A/FZD4/JNK pathway is effective in in-
ducing osteogenesis in mouse bone marrow (BM)- derived MSCs via 
mechanical loading.21 Recently, it has been shown that the release of 
FnIII- 1c is controlled by mechanical forces and proteolysis.17 It was 
recently clarified that TLR4 performed its role in osteogenesis via 
Wnt5a in mouse BM- MSCs,22 but its role in humans is not known.
Studies have not yet determined a relationship between the pat-
tern of TLR4 expression (in the presence and absence of endogenous 
and exogenous ligands) and the pattern of gene expression during 
differentiation of MSCs into fat and cartilage cells. Moreover, the 
effect of FnIII- 1c as a stress signal on the differentiation potential of 
human MSC into bone, fat and chondrocyte cells is unknown.
In the present study, we tried to elucidate the molecular mech-
anisms and functions of TLR4 during the differentiation of human 
MSCs into three lineages. First, we studied expression patterns of 
TLR4 during differentiation into the three lineages and then cre-
ated a model for inducing pathogen- related and tissue damage- 
related stress conditions through the activation of TLR4 via LPS 
and FnIII- 1c, respectively. Second, the expression of genes during 
differentiation of MSCs into all three lineages in the presence of 
both ligands was investigated. Given that so far there is no report 
on the effect of TLR4 knockdown on the differentiation capabilities 
of human MSCs into any of the three lineages, the function of TLR4 
was evaluated by its knockdown in MSCs during differentiation into 
the respective lineages. In addition, we also investigated whether 
the release of FnIII- 1c due to mechanical forces and proteolysis can 
affect the differentiation of human MSCs via Wnt5a expression. 
We examined the involvement of Wnt5a in the differentiation in-
duced by TLR4.
2  | MATERIAL S AND METHODS
2.1 | Cell culture
hMSCs were acquired from the Stem Cell Bank of the Royan Institute 
in this study. The cells were cultured in α- MEM (Gibco, Catalog No. 
12571) supplemented with 10% FBS (Gibco, Catalog No. 10270106), 
and 1% penicillin/streptomycin (Sigma, Catalog No. 15- 070- 063). 
Cells in the 3rd passage were used for the experiments.
2.2 | Multilineage differentiation 
potential of hMSCs
hMSCs were seeded at a density of 2 × 104 cells/cm2 in a 6- well 
plate with DMEM supplemented with 10% FBS, and 1% penicillin/
streptomycin. After 24 hours, the basic medium was replaced with 
osteogenic and adipogenic differentiation medium with or without 
LPS 1 µg/mL (Invivogen, Catalog No. tlrl- peklps) or FnIII- 1c 1 µg/mL 
(Sigma- Aldrich, Catalog No. F3542). For chondrogenic differentia-
tion, these ligands were added into pellets containing chondrogenic 
K E Y W O R D S
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medium. Treatment was performed at the following time- points: 7, 
14 and 21 days.
For induction of osteogenic differentiation, DMEM supple-
mented with 10% FBS, 10 mM β- glycerophosphate (Sigma- Aldrich, 
Catalog No. 154804- 51- 0), 10−8 M dexamethasone (Sigma- Aldrich, 
Catalog No. D4902) and 50 µg/mL ascorbic acid (Sigma- Aldrich, 
Catalog No. A8960).
For induction of adipogenic differentiation, BM- MSCs were 
cultured in adipogenic medium that contained DMEM supple-
mented with 10% FBS, 50 µg/mL indomethacin (Sigma- Aldrich, 
Catalog No. 53- 86- 1), 50 µg/mL ascorbic acid and 1 × 10−7 M 
dexamethasone.
For chondrogenic differentiation, 15 mL polypropylene tube was 
used to seed 2 × 105 cells and centrifuged at 250 g for 5 minutes at 
room temperature until pellets were formed. After centrifugation, the 
supernatant was gently removed and the pellets were cultured in chon-
drogenic medium, which contained DMEM as the basic medium supple-
mented with 10 ng/mL human transforming growth factor- 1 (Fitzgerald, 
Catalog No. 30R- AT027), 10−7 M dexamethasone, 50 µg/mL ascorbic 
acid, 1% non- essential amino acids (Gibco, Catalog No. 11140- 035) and 
1% ITS (Gibco, REF. 41400- 045). The characterization of osteogenic, 
adipogenic and chondrogenic differentiation was performed by Alizarin 
red, Oil red O and toluidine blue/safranin- O staining, respectively.
2.3 | Alizarin red quantification
Alizarin red quantification was used for the evaluation of miner-
alization of the cells on exposure to FnIII- 1c at the following con-
centrations: 0.5, 1 and 1.5 µg/mL. First, the cells were fixed with 
4% paraformaldehyde, and then Alizarin red was used for staining. 
Alizarin red quantification (Sigma- Aldrich, Catalog No. ECM815) was 
performed according to the manufacturer's instructions by measur-
ing absorbance at 405 nm in a microplate reader.
2.4 | Alkaline phosphatase (ALP) activity
The effects of TLR4 ligands and TLR4 knockdown on the differentia-
tion of BM- MSCs into osteoblast cells were investigated as a func-
tion of ALP activity after 7, 14 and 21 days. An alkaline phosphatase 
assay kit (Colorimetric, Abcam, Catalog No. ab83369) was used to 
measure activity according to the manufacturer's protocol. The BCA 
protein (Novagen, Catalog No. 71285- 3) assay kit was used to de-
termine the protein concentration. The specific activity was deter-
mined through enzyme activity normalized by total protein content.
2.5 | RNA interference
The cells were seeded at a density of 2 × 105 cells in 6- well plates. 
Transfection of hMSCs was performed using psiRNA- hTLR4 or 
psiRNA- LucGL3 (control plasmid) (InvivoGen, Catalog No. ksirna42- 
htlr4), and the lipofectamine 3000 (Invitrogen, Catalog No. 
L3000075) reagent according to the manufacturer's instructions. 
siRNA- induced silencing of TLR4 gene was determined by Real- time 
PCR and western blot techniques.
2.6 | Real- time PCR
To study the expression levels of genes involved in osteogenic, 
adipogenic and chondrogenic differentiation (For more details, 
see Table S1) as well as Wnt5a and TLR4, total RNA was ex-
tracted by TRI reagent (Sigma- Aldrich, Catalog No. T9424) from 
cultured MSCs that were differentiated, and were untreated 
or treated with LPS/FnIII- 1c on days 0, 7, 14 and 21. To elimi-
nate genomic DNA, RNAs were treated with DNase I (TAKARA, 
Catalog No. 2270A), according to the manufacturer's protocol. 
The PrimeScript™ RT reagent kit (TAKARA, Catalog No. RR037A) 
was used for cDNA synthesis from 1 μg total RNA. All real- time 
polymerase chain reactions (PCR) were performed using SYBR 
Green Master Mix (Applied Biosystems Life Technologies, Inc, 
REF 4367659) and StepOnePlus Real- time PCR System (Applied 
Biosystems Life Technologies, ABi) with the programme that was 
as follows: holding stage: 95°C (10 minutes), cycling stage: 95°C 
(15 seconds), 60°C (1 minutes) for 40 cycles. The melting curve 
stage was followed by a dissociation stage: 95°C (15 seconds), 
60°C (1 minutes), and 95°C (15 seconds). β- actin was used as an 
endogenous control to normalize all the target mRNAs. All biolog-
ical groups were compared to the control group. The gene expres-
sion data analysis was carried out by 2−ΔΔCT method. In Table S1, 
the sequence of the specific primers for each gene is listed.
2.7 | Western blot analysis
The hMSCs transfected with psiTLR4 were washed twice with 
cold PBS and proteins were extracted using Mammalian Protein 
Prep Kit (QIAGEN, Catalog No. 37901) with protease and phos-
phatase inhibitors. The protein concentration was measured using 
the Bradford assay. Proteins were loaded on 10% SDS polyacryla-
mide gel and transferred onto PVDF membranes (Membrane 
Solutions). Non- specific binding was blocked with 5% skim milk 
for 1 hr. The blocked membranes were incubated with anti- TLR4 
primary antibody (1:500, Abcam, Catalog No. ab22048) and β- 
actin antibody (1:5000, Thermo Fisher Scientific, Catalog No. 
60008- 1- IG), then washed and incubated with horseradish per-
oxidase (HRP)- conjugated secondary antibodies (1:30 000, Sigma- 
Aldrich, Catalog No. 12- 349) for 1 hour at room temperature. 
Specific protein bands were identified by the ECL prime western 
blotting detection reagent (Amersham/GE Healthcare, Catalog 
No. RPN2232) and proteins were visualized by the chemilumines-
cence imaging system (UVITEC Cambridge).
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2.8 | Statistical analysis
Data were analysed using Prism statistical software (version 8). The 
statistical significance of the differences between groups was de-
termined by one- way analysis of variance (ANOVA) and followed by 
post hoc Tukey test. Also, the comparison between the two groups 
was done with t- test. A P- value of .05 was considered significant.
3  | RESULTS
3.1 | TLR4 expression increased during osteogenic, 
chondrogenic and adipogenic differentiation of 
hMSCs
To determine whether osteogenic, chondrogenic and adipogenic 
differentiation can affect TLR4 expression, human BM- MSCs were 
cultured and differentiated into three different lineages using induc-
tion media for 7, 14 and 21 days. The cells also were treated with 
1 µg/mL LPS, this concentration was selected based on a previous 
study.23,24 To determine whether FnIII- 1c affects the osteogenic and 
adipogenic differentiation of MSCs, we added FnIII- 1c in an appro-
priate dose (0.5, 1 and 1.5 µg/mL) to the differentiation media of 
relevant at 7 days. The FnIII- 1c strongly stimulated the osteogenic 
differentiation of MSCs at a concentration of 1 µg/mL (based on 
alizarin red quantification and alizarin red staining), whereas it did 
not affect adipogenic differentiation (Oil red O staining). Therefore, 
a concentration of 1 µg/mL FnIII- 1c, was selected based on total re-
sults (Figure 1A- C). TLR4 expression increased during osteogenesis, 
adipogenesis and chondrogenesis (Figure 2A- C). LPS increased TLR4 
expression on days 7 and 14 during osteogenesis significantly com-
pared with the untreated differentiated group (Figure 2A). During 
adipogenesis, FnIII- 1c activation remarkably increased TLR4 ex-
pression on day 21 compared with the untreated group (Figure 2B). 
During chondrogenic differentiation, TLR4 expression on treatment 
with FnIII- 1c was significantly increased from day 14 (Figure 2C).
3.2 | Both LPS and FnIII- 1c activation promoted 
osteogenic differentiation of hMSCs
To detect whether TLR4 affects osteogenic differentiation differ-
ently upon exposure to its ligands, hMSCs were cultured in the 
absence or presence of 1 µg/mL LPS or FnIII- 1c in osteogenic 
media for TLR4 activation. ALP activity measurement and real- 
time PCR were conducted for the assessment of osteogenesis in 
the MSCs at various time- points. The levels of RUNX2, OCN and 
bone morphogenetic protein 2 (BMP2) on stimulation of FnIII- 1c 
on day 7 were higher than in the untreated group. RUNX2, OCN 
and BMP2 expression on days 7 and 14 on treatment with LPS 
compared with the untreated group were significantly enhanced 
(Figure 3A- C). FnIII- 1c stimulation significantly decreased BMP2 
expression in comparison with LPS and the untreated groups on 
day 21 (Figure 3C).
Assessment of osteogenesis by Alizarin red staining con-
firmed the formation of a mineralized matrix on days 7, 14 and 21 
(Figure 3E). The results of ALP activity showed that FnIII- 1c affected 
the ALP activity remarkably on day 7 compared to the control group 
(Figure 3D) and ALP activity after LPS treatment was higher than in 
the control group on day 14.
F I G U R E  1   Effect of FnIII- 1c ligand on osteogenic and adipogenic differentiation of hMSCs. MSCs were cultured under different 
concentrations of FnIII- 1c in osteogenic and adipogenic media for 7 d, differentiation potential was evaluated through (scale bar = 200 mm) 
(A) Alizarin red quantification, (B) its staining and (C) Oil Red O staining in appropriate dose (0.5, 1 and 1.5 µg/mL)
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3.3 | TLR4 activation by LPS and FnIII- 1c decreased 
adipogenic differentiation of hMSCs
We investigated whether the expression of relevant adipogenesis 
genes changed after adding endogenous and exogenous TLR4 li-
gands to MSCs cultured in adipogenic medium. The expression of 
FABP4, and LPL mRNA declined after LPS and FnIII- 1c treatment 
compared to the untreated differentiated group on days 14 and 21, 
and PPARγ mRNA expression significantly decreased only on day 21 
(Figure 4A- C). After 21 days, cells cultured in the presence of LPS 
and FnIII- 1c showed a staining density lower than that of the un-
treated group (Figure 4D).
F I G U R E  2   TLR4 expression during the differentiation of MSCs into the three respective lineages in the presence and absence of LPS 
or FnIII- 1c. MSCs were cultured for differentiation into three lineages then the cells were treated with and without 1 µg/mL LPS or FnIII- 
1c for 7, 14 and 21 days. The mRNA levels of TLR4 were detected in cells cultured in (A) osteogenic, (B) adipogenic, and (C) chondrogenic 
media using real- time PCR. Data are presented as mean ± SEM of ratios relative to β- actin levels (n = 3). *P < .05, **P < .01, ***P < .001, 
****P < .0001
F I G U R E  3   Effect of LPS and FnIII- 1c activation on the expression of genes involved in osteogenic differentiation of hMSCs. MSCs were 
cultured under osteogenic medium with and without 1 µg/mL LPS or FnIII- 1c for 7, 14 and 21 d for all the experiments mentioned below. The 
mRNA levels of (A) Runt- related transcription factor 2, (B) osteocalcin, and (C), bone morphogenetic protein- 2 were evaluated using real- time 
PCR. (D) ALP activity measurement and (E) characterization of hMSCs were conducted using Alizarin red staining (scale bar = 200 mm), 
MSCs were cultured in DMEM medium in the control group (Con). Data are presented as mean ± SEM of ratios relative to β- actin levels 
(n = 3). *P < .05, **P < .01, ***P < .001, ****P < .0001
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3.4 | TLR4 activation by LPS but not FnIII- 1c 
enhanced chondrogenic differentiation of hMSCs
To verify whether TLR4 endogenous and exogenous ligands affect 
the chondrogenic differentiation of hMSCs, LPS and FnIII- 1c were 
added to the chondrogenic medium. LPS stimulated the mRNA ex-
pression of SOX9 and COL2A1 compared to the untreated group 
on day 21 but FnIII- 1c activation strongly decreased expression of 
both SOX9 and COL2A1 compared to the untreated differentiated 
group (Figure 5A,B). After 21 days, the pellets that were cultured 
with and without LPS or FnIII- 1c were assessed for the chondrogenic 
phenotype using toluidine blue and Safranin- O staining, the LPS and 
untreated groups had acquired a clear phenotype of differentiation 
in comparison with the FnIII- 1c group (Figure 5D,E).
3.5 | Knockdown of TLR4 promotes 
adipogenesis, impairs osteogenesis and partially 
chondrogenesis of hMSCs
psiRNA- hTLR4 was used for knockdown of TLR4 in hMSCs. The 
knockdown of TLR4 was confirmed by mRNA expression and protein 
levels of TLR4 (Figure 6A- G). Then, the effect of TLR4 knockdown 
on the differentiation potential of MSCs into osteogenic (Figure 7A- 
C), adipogenic (Figure 7D- F) and chondrogenic (Figure 7G- I) lineages 
were evaluated by examining mRNA expression during differen-
tiation. TLR4 expression was lower on LPS treatment of the TLR4 
knockdown group compared to the LPS- psiRNA- LucGL3 group on 
day 7 (P < .01) (Figure 6E). TLR4 knockdown suppressed mRNA ex-
pression of OCN and BMP2 on day 21 during osteogenic differentia-
tion (Figure 7B,C). In adipogenic differentiation, the knockdown of 
TLR4 increased FABP4 mRNA expression in differentiated hMSCs 
on days 7 and 14. Additionally, LPL expression in the TLR4 knock-
down group was significantly higher than in the control group on 
day 21 (Figure 7D- F). In chondrogenic differentiation, knockdown of 
TLR4 showed lower ACAN expression in comparison with the con-
trol group on day 21 (Figure 7I). ALP activity in the untreated group 
reached its maximum on day 14. The highest peak of ALP activity in 
the FnIII- 1c group was achieved on day 7. It was also observed that 
the TLR4 knockdown caused a decrease in ALP activity. Though ALP 
activity increased on treatment with LPS on day 7, the highest peak 
of activity was observed on day 14, and the TLR4 knockdown caused 
a decrease in activity here as well (Figure 7J).
3.6 | LPS promoted Wnt5a expression during 
osteogenesis in a stage- dependent manner and FnIII- 
1c inhibited Wnt5a expression during adipogenesis
We analysed whether stress- induced ligand (FnIII- 1c) can stimulate 
MSC differentiation into the three respective lineages in compari-
son with pathogen ligand (LPS). During osteogenic differentiation, 
Wnt5a expression increased in a time- dependent manner, and LPS 
treatment significantly enhanced the Wnt5a level on day 7 (P < .0001) 
(Figure S1). Wnt5a expression upon FnIII- 1c activation significantly 
decreased during osteogenesis and adipogenesis on days 7, 14 and 
21 in comparison with the untreated group (Figure S1). During chon-
drogenic differentiation, Wnt5a expression on treatment with and 
without LPS or FnIII- 1c reached a maximum on day 14 (Figure S1). 
During osteogenesis, Wnt5a expression was decreased in the TLR4 
knockdown group in all three time- points compared to in the control 
group, however, this difference was not significant (Figure S1). After 
knockdown of TLR4, there was no significant difference in Wnt5a 
levels between the control and TLR4 knockdown group upon adi-
pogenesis induction (Figure S1). However, during chondrogenesis, 
upon TLR4 knockdown, Wnt5a expression was significantly higher 
than in the control group on day 21 (Due to differences between 
tested groups during chondrogenesis on day 21, the TLR4 knock-
down effects were studied at this time- point) (Figure S1).
4  | DISCUSSION
The effect of TLR4 on the differentiation potential of MSCs is not 
clear. Our study for the first time showed that TLR4 expression in-
creased under osteogenic, adipogenic and chondrogenic induction 
of MSCs. The stress- induced ligand (FnIII- 1c) of TLR4 increased os-
teogenesis in the early stages of differentiation. TLR4 knockdown 
suppressed osteogenesis and partially chondrogenesis, however, it 
increased adipogenesis. Wnt5a expression was inversely related to 
the late stage of chondrogenesis in the process.
Our results show that the TLR4 expression was enhanced in 
hMSCs upon differentiation into the three lineages, hence osteo-
blasts, adipocytes and chondrocytes earned the capacity to enhance 
the expression of TLR4 during related differentiation. However, the 
baseline expression of TLR4 in MSCs helps to maintain self- renewal 
properties. TLR4 expression upon LPS stimulation increased greatly 
in the early stages of MSCs differentiation into osteoblasts, then its 
expression gradually declined. Mo et al23 showed that long- term ex-
posure to LPS causes down- regulation of TLR2 and TLR4 expression 
in osteoprogenitors. They observed that endotoxin negatively reg-
ulates TLR4 expression and this event is also observed in immune 
cells such as monocytes.23 This phenomenon was not observed in 
our study in either adipocytes or chondrocytes, it is likely that the 
event is cell- type- specific.
Transfer of LPS to the TLR4/MD2 complex is facilitated by LBP 
and CD14, but this transition of LPS to the molecular complex is a 
dynamic process required for the activation of the immune system.25 
Therefore, this dynamic process may also affect the potential for the 
differentiation of the MSCs. In dermal fibroblasts, it has been shown 
that differences in the response of TLR4 to Tenascin C, FnIII- 1c or 
FnEDA may be due to differences in the co- receptor that stimulate 
it. Therefore, the heterogeneity of the TLR4 receptor complex varies 
as a function of TLR4 activation.17
TLRs regulate many functions of MSCs upon stimulation by 
their ligands.26 LPS treatment did not affect the properties of 
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immunosuppression and immunogenicity in human adipose- 
derived stem cells (hASCs).27 Proliferation in mouse BM- MSCs 
was enhanced following TLR4 stimulation.28 Recently, it has been 
shown that different responses occur on stimulation of TLR de-
pending on the species (human or mouse) as well as the cell type 
of MSCs.9,29,30
Therefore, we evaluated whether a pattern of TLR4 expression is 
linked with the pattern of gene expression during the differentiation 
of human MSCs into the three respective lineages. In our study, both 
LPS and FnIII- 1c increased osteogenesis on day 7 sharply, however, 
ALP activity on treatment with FnIII- 1c reached its peak faster (on 
day 7) as compared to LPS activation (on day 14). Fibronectin prob-
ably released from injured sites can accelerate calcium deposition at 
the early stage of osteogenesis (on day 7) compared with LPS, which 
is an endotoxin (on day 14). This is important in the case of MSCs 
that transplanted for bone regeneration. Raicevic et al31 demon-
strated that LPS (10 µg/mL) increased osteogenesis in ADSCs more 
than hMSCs, but it did not influence osteogenesis in Wharton's Jelly 
(WJ). Because of the constitutively low potential for osteogenesis in 
WJ, TLR4 activation did not affect it. Hwa Cho et al32 demonstrated 
that osteogenesis was enhanced after stimulation with osteogenic 
media treated with LPS in hADSCs. LPS (1 µg/mL) inhibited osteo-
genic and adipogenic differentiation compared to the control group 
in mouse MSCs.33 Recently, it has been shown that long- term ex-
posure to LPS (1 μg/mL and 10 μg/mL) can elevate calcium and ALP 
levels in MSCs on day 10. They suggested that the low expression of 
TLR4 is a mechanism of MSCs that protect from bacterial toxins and 
increases survival rates.23
F I G U R E  4   Effect of LPS and FnIII- 1c activation on the expression of genes involved in adipogenic differentiation of hMSCs. MSCs were 
cultured under adipogenic medium with and without 1 µg/mL LPS or FnIII- 1c for 7, 14 and 21 d for all the experiments mentioned below. The 
mRNA levels of (A) lipoprotein lipase, (B) Fatty acid- binding protein 4 (FABP4), and (C) peroxisome proliferator- activated receptor gamma 
(PPAR- γ) were evaluated using real- time PCR. (D) Characterization of hMSCs was conducted using Oil Red O staining (scale bar = 100 mm). 
Data are presented as mean ± SEM of ratios relative to β- actin levels (n = 3). *P < .05, **P < .01, ***P < .001, ****P < .0001
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Our results showed that chondrogenesis was increased by LPS 
in the late stage (on day 21) of differentiation whereas fibronectin 
inhibited it. This study for the first time showed that stimulation of 
the TLR4 by endogenous and exogenous ligands has different ef-
fects on the differentiation of MSCs into cartilage. Further research 
is required to focus on these findings.
Kim et al34 demonstrated that LPS increased the chondrogenic 
differentiation of UCMSCs for 3 weeks. One study revealed that 
TLR functionality is determined by a variety of pathways such as 
LBP and TGFβ1.35 Recently, a report showed that in addition to 
the role of TGFβ in the modulation of the immune system,36 it has 
a role in increasing collagen deposition in LPS- primed MSCs while 
the deposition of fibronectin increased in poly(I: C)- primed MSCs (a 
TLR3 ligand) which was associated with decreased levels of TGFβ.37 
Therefore, the duration of exposure with a ligand, the type of ligand, 
the stage of differentiation, pathways of TLR stimulation (endoge-
nous or exogenous), the concentration of ligand, the type and spe-
cies of cells can affect the differentiation potential of MSC.
FnIII- 1c may affect different pathways and mechanisms in-
volved in osteogenesis and chondrogenesis depending on the stage 
of differentiation and the gene network involved in each step. In 
a study, the probable cause of the limited effects of TLR4 stimu-
lation by fibronectin, the effect of the endogenous ligand on sev-
eral receptor classes in addition to the TLR4 in these cells were 
reported.10
In hMSCs, after stimulation by LPS, expression of IL- 1β, IL- 6 and 
tumour necrosis factor (TNF)- a was enhanced but treatment with 
fibronectin led to an increase in the production of matrix metallo-
proteinase- 3 (MMP3).10 Production of IL- 6 was increased after a 
bone fracture in the inflammatory phases of fracture healing.38 In 
another study, LPS in addition to producing inflammatory cytokines, 
increased IP10 (CXCL10) expression that was activated via IFN1β, in-
dicating that LPS has affected both MyD88- dependent and MyD88- 
independent pathways of hASCs.39 The MMPs play a role in ECM 
degradation, during chondrogenesis the levels of proteoglycans in-
creased, which was associated with increased levels of genes related 
to ECM and decreased levels of MMP3.40 Overall it seems the pro-
duction of cytokines upon TLR4 stimulation by LPS or fibronectin 
affects MSC fate into bone or cartilage.
To elucidate whether TLR4 is involved in MSC differentiation, 
we investigated if TLR4 knockdown affects the expression of genes 
involved in the differentiation into the three separate lineages of 
F I G U R E  5   Effect of LPS and FnIII- 1c activation on the expression of genes involved in chondrogenic differentiation of hMSCs. MSCs 
were cultured in 15 mL polypropylene tube under chondrogenic medium with and without 1 µg/mL LPS or FnIII- 1c for 7, 14 and 21 d for all 
the experiments mentioned below. The mRNA levels of (A) SOX9, (B) type II collagen (COL2A1), and (C) Aggrecan (ACAN) was evaluated by 
real- time PCR. Characterization of hMSCs was conducted using (D) toluidine blue, and (E) safranin- O staining (scale bar = 100 and 200 mm 
respectively from the right in each column). Data are presented as mean ± SEM of ratios relative to β- actin levels (n = 3). *P < .05, **P < .01, 
***P < .001, ****P < .0001
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MSCs. Expression of osteogenesis- related genes after TLR4 knock-
down was decreased on day 21. LPS treatment during osteogenesis 
in the TLR4 knockdown group significantly decreased TLR4 expres-
sion in comparison to the LPS- psiRNA- LucGL3 group, to a lesser ex-
tent, in the fibronectin group.
TLR4 knockdown promoted adipogenesis in hMSCs. ACAN ex-
pression in the TLR4 knockdown group was significantly suppressed 
as compared to in the untreated group on day 21 indicating that 
chondrogenesis was partially suppressed. It also suggests the prob-
ability that pathways other than TLR4 are involved in chondrogen-
esis. In mice with MyD88- deficient MSCs, upon stimulation of LPS 
induction of secretion of IL- 6 was not observed, osteogenesis and 
chondrogenesis were impaired, and they notably differentiate into 
adipocytes.26 Down- regulation of MyD88 inhibited osteogenesis 
and adipogenesis in hASCs.39
The molecular mechanism of TLR4 in the differentiation of 
hMSCs into three lineages is still unknown. However, the MAPK 
pathway also plays a role in the osteogenesis of MSCs.41 Maximum 
ERK activation was observed during osteogenesis of hADSCs at day 
7 which LPS stimulation enhanced.32 Stimulation of both LPS and 
fibronectin triggered the phosphoinositide 3- kinase (PI3K) pathway, 
upstream of the MAPK and NF- κB pathways in hMSCs.10 Recently, 
it has been shown that FnIII- 1c activates p38 MAP kinase and stable 
mRNA IL- 8.17 Therefore, it suggests that fibronectin may exert its 
effect on osteogenesis via MAPK.
Another pathway involved in the differentiation of MSCs is the 
Wnt5a pathway. TLRs and NF- kB pathways play a role in Wnt5a 
expression.42 In human dental pulp stem cells, Wnt5a expression 
increased due to LPS via the pathways of TLR4/MyD88, NF- kB or 
PI3K/AKT.43 It has been shown that TLRs alone are not enough for 
the regulation of the expression of Wnt5a but it was suggested that 
particular requirements for cell type and condition of differentiation 
could also affect.42
These results raise the possibility that TLR4 may play a diverse 
role in regulating Wnt signalling in different tissues. Overexpression 
of Wnt5a via the promoter of osteopontin drives osteogenesis in 
MSCs and suppressing Wnt5a promoted differentiation of MSCs into 
pre- adipocytes.44 In our study, up- regulation of Wnt5a expression 
was observed during osteogenesis and adipogenesis and it seems 
that Wnt5a stimulation by LPS increases osteogenesis on day 7. 
Fibronectin is released in unfavourable conditions under mechanical 
stimulation in damaged tissues, through up- regulated Wnt5a which 
could not increase osteogenesis. There was a difference in Wnt5a 
expression between the TLR4 knockdown (lower) and the control 
group, however, it was not significant in osteogenesis. Wnt5a expres-
sion in the tested groups increased until day 14 during chondrogene-
sis and then decreased on day 21. A study demonstrated that Wnt5a 
expression was promoted in the early stages of chondrogenesis via 
SOX9 by the induction of calmodulin kinase or the nuclear factor 
of activated T cells (NFAT).45 In the stages of early chondrogenesis, 
F I G U R E  6   TLR4 silencing by psiTLR transfection. MSCs were transfected with psiTLR4 and psiRNA- LucGL3 (control). (A) TLR4 levels 
in the TLR4 knockdown and control groups were detected through western blotting. MSCs were transfected with psiTLR4, transfection of 
hMSCs with psiTLR4 was confirmed using (B) fluorescence microscope, and (C) light microscope (Scale bar = 200 mm). (D) merged state is 
shown. TLR4 expression after knockdown of TLR4 in MSCs during (E) osteogenic, (F) adipogenic, and (G) chondrogenic differentiation was 
detected using real- time PCR. Data are presented as mean ± SEM of ratios relative to β- actin levels (n = 3). *P < .05, **P < .01, ***P < .001, 
****P < .0001
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F I G U R E  7   Effect of TLR4 knockdown on the expression of genes involved in osteogenic, adipogenic and chondrogenic differentiation. 
MSCs were transfected with psiRNA- hTLR4 (SiTLR4 group) and psiRNA- LucGL3 (control group). The mRNA levels of (A) Runt- related 
transcription factor 2, (B) osteocalcin, (C) bone morphogenetic protein- 2, (D) lipoprotein lipase, (E) Fatty acid- binding protein 4 (FABP4), 
(F) peroxisome proliferator- activated receptor gamma (PPAR- γ), (G) SOX9, (H) type II collagen (COL2A1) and (I) Aggrecan (ACAN) were 
evaluated using real- time PCR for (A- C) osteogenic (D- F) adipogenic and (G- I) chondrogenic differentiation, respectively. (J) ALP activity of 
treated groups undergoing osteogenic differentiation was evaluated, MSCs were cultured in DMEM medium in the control group (Con). Data 
are presented as mean ± SEM of ratios relative to β- actin levels (n = 3). *P < .05, **P < .01, ***P < .001, ****P < .0001
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Wnt5a suppresses the canonical pathway for differentiation into 
cartilage, however, it induces the non- canonical pathway which con-
tributes to the destruction of cartilage.46 Therefore, it seems that 
Wnt5a plays a role in the onset of chondrogenic differentiation. To 
determine definitively the effect of Wnt5a on the differentiation of 
mesenchymal stem cells, the effect of Wnt5a siRNA on the differ-
entiation of hMSCs in the absence and presence of TLR4 agonists 
should be determined.
5  | CONCLUSION
We observed that TLR4 expression increased during the differentia-
tion of MSCs into all three lineages. However, the basic expression 
of TLR4 is the mechanism that preserves the self- renewal capacity 
of MSCs. We also revealed that TLR4 knockdown suppresses os-
teogenesis while promoting adipogenesis in human MSCs. Our data 
clarify that the FnIII- 1c promotes osteogenesis in the early stages of 
differentiation but it decreased chondrogenesis in the late stage of 
the process.
Up- regulation of TLR4 has a direct link with enhanced osteogen-
esis and chondrogenesis depending on the type of ligand and the 
stage of differentiation but its expression was inversely related to 
adipogenesis. This study elucidates how the presence of stress or 
pathogens alters TLR4 expression and if the differentiation potential 
of MSCs is affected, which is important to comprehend from a clini-
cal or treatment perspective.
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